$2.32
▲ +$0.13
(+5.94%)
Vol 450K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$131.4M
ROE
-27.7%
D/E
0.00
Beta
0.53
52W
$1–$3
Wall Street Consensus
12 analysts · Apr 20264
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
91.7%
Buy Rating
Price Chart
Similar Stocks
CNTB
Connect Biopharma Holdings Ltd
$157.6M
PRLD
Prelude Therapeutics Inc
$164.2M
ARTV
Artiva Biotherapeutics Inc
$105.3M
RNAC
Cartesian Therapeutics Inc
$187.5M
WHWK
Whitehawk Therapeutics Inc
$114.1M
ABOS
Acumen Pharmaceuticals Inc
$127.8M
VTVT
vTv Therapeutics Inc
$167.1M
KALA
KALA BIO Inc
$12.2M
IMUX
Immunic Inc
$64.2M
TNYA
Tenaya Therapeutics Inc
$154.0M
Earnings
Beat rate: 80.0%
Next Report
May 12, 2026
EPS Estimate: $-0.36
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.36 | — | — |
| Dec 2025 | $-0.32 | $-0.37 | $-0.05 |
| Sep 2025 | $-0.32 | $-0.29 | +$0.03 |
| Jun 2025 | $-0.36 | $-0.31 | +$0.05 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -27.7% | -26.6% | -27.7% | -27.7% | -27.7% | -27.7% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 15.67 | 14.48 | 15.67 | 15.67 | 15.23 | 15.23 |
Key Ratios
ROA (TTM)
-22.2%
P/B
0.4
EPS (TTM)
$-1.39
CF/Share
$-2.41
52W High
$2.74
52W Low
$1.31
$1.31
52-Week Range
$2.74
How does NKTX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
NKTX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.4
▼
82%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
NKTX profitability vs Biotechnology peers
ROE
-27.7%
▲
59%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-22.2%
▲
52%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
NKTX financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
15.2
▲
243%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.5
▼
45%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
NKTX fundamentals radar
NKTX
Peer median
Industry
NKTX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
NKTX vs peers: key metrics
Latest News
No related news yet